FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kent Weinhold

Research Profile

Living Beings

HIV-1
HIV

Disorders

HIV Infections

Chemicals & Drugs

Anatomy

Procedures

Physiology

Co-author Network

Publications

TOP 3
Gina Shetty; Sara Sparks; Douglas S Tyler; Michael Barfield; Georgia M Beasley; Cliburn Chan; Melanie Masoud; Paul J Mosca; Scott K Pruitt; April K S Salama; Kent J Weinhold
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.
Stephanie A Freel; Barton F Haynes; John C Kappes; Jennifer L Kirchherr; Andrew J McMichael; Christina Ochsenbauer; Ralph A Picking; Kelly A Soderberg; Myron S Cohen; John A Crump; Coleen K Cunningham; Thomas N Denny; Haitao Ding; Guido Ferrari; Kent J Weinhold; Georgia D Tomaras
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
David M Murdoch; Janet S Staats; Kent J Weinhold
OMIP-006: phenotypic subset analysis of human T regulatory cells via polychromatic flow cytometry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kent Weinhold (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gina Shetty; Sara Sparks; Douglas S Tyler; Michael Barfield; Georgia M Beasley; Cliburn Chan; Melanie Masoud; Paul J Mosca; Scott K Pruitt; April K S Salama; Kent J Weinhold
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.
Annals of surgical oncology 2013;20(4):1128-35.
2012: Stephanie A Freel; Barton F Haynes; John C Kappes; Jennifer L Kirchherr; Andrew J McMichael; Christina Ochsenbauer; Ralph A Picking; Kelly A Soderberg; Myron S Cohen; John A Crump; Coleen K Cunningham; Thomas N Denny; Haitao Ding; Guido Ferrari; Kent J Weinhold; Georgia D Tomaras
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
Journal of virology 2012;86(12):6835-46.
2012: David M Murdoch; Janet S Staats; Kent J Weinhold
OMIP-006: phenotypic subset analysis of human T regulatory cells via polychromatic flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2012;81(4):281-3.
2011: Justin Pollara; Mario Roederer; Georgia D Tomaras; Kent J Weinhold; Faraha Brewer; Lydia Hart; Barton F Haynes; James A Hoxie; Ying Huang; John C Kappes; Akira Komoriya; David C Montefiori; Christina Ochsenbauer; Beverly Z Packard; Joy Pickeral; Guido Ferrari
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2011;79(8):603-12.
2011: Guido Ferrari; Bette Korber; Nilu Goonetilleke; Michael K P Liu; Emma L Turnbull; Jesus F Salazar-Gonzalez; Natalie Hawkins; Steve Self; Sydeaka Watson; Michael R Betts; Cynthia Gay; Kara McGhee; Pierre Pellegrino; Ian Williams; Georgia D Tomaras; Barton F Haynes; Clive M Gray; Persephone Borrow; Mario Roederer; Andrew J McMichael; Kent J Weinhold
Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.
PLoS pathogens 2011;7(2):e1001273.
2010: Cliburn Chan; Lin Lin; Jacob Frelinger; Valérie Hérbert; Dominic Gagnon; Claire Landry; Rafick-Pierre Sékaly; Jennifer Enzor; Janet Staats; Kent J Weinhold; Maria Jaimes; Mike West
Optimization of a highly standardized carboxyfluorescein succinimidyl ester flow cytometry panel and gating strategy design using discriminative information measure evaluation.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2010;77(12):1126-36.
2010: Barney S Graham; M Juliana McElrath; Michael C Keefer; Kyle Rybczyk; David Berger; Kent J Weinhold; Janet Ottinger; Guido Ferarri; David C Montefiori; Don Stablein; Carol Smith; Richard Ginsberg; John Eldridge; Ann Duerr; Patricia Fast; Barton F Haynes
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.
PloS one 2010;5(8):e11995.
2009: Nilu Goonetilleke; Michael K P Liu; Jesus F Salazar-Gonzalez; Guido Ferrari; Elena Giorgi; Vitaly V Ganusov; Brandon F Keele; Gerald Learn; Emma L Turnbull; Maria G Salazar; Kent J Weinhold; Stephen Moore; Norman Letvin; Barton F Haynes; Myron S Cohen; Peter Hraber; Tanmoy Bhattacharya; Persephone Borrow; Alan S Perelson; Beatrice H Hahn; George M Shaw; Bette T Korber; Andrew J McMichael
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.
The Journal of experimental medicine 2009;206(6):1253-72.
2009: Xiaoying Shen; Robert J Parks; David C Montefiori; Jennifer L Kirchherr; Brandon F Keele; Julie M Decker; William A Blattner; Feng Gao; Kent J Weinhold; Charles B Hicks; ML Greenberg; Beatrice H Hahn; George M Shaw; Barton F Haynes; Georgia D Tomaras
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth.
Journal of virology 2009;83(8):3617-25.
2009: David M Murdoch; Melinda S Suchard; Willem D F Venter; Patrick Mhlangu; Janet S Ottinger; Charles Feldman; Annelies van Rie; Deborah K Glencross; Wendy S Stevens; Kent J Weinhold
Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).
AIDS research and therapy 2009;6():16.
2008: Georgia D Tomaras; Nicole L Yates; Pinghuang Liu; Li Qin; Genevieve G Fouda; Leslie L Chavez; Allan C Decamp; Robert J Parks; Vicki C Ashley; Judith T Lucas; Myron Cohen; Joseph J Eron; Charles B Hicks; Hua-Xin Liao; Steven G Self; Gary Landucci; Donald N Forthal; Kent J Weinhold; Brandon F Keele; Beatrice H Hahn; ML Greenberg; Lynn Morris; Salim S Abdool Karim; William A Blattner; David C Montefiori; George M Shaw; Alan S Perelson; Barton F Haynes
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
Journal of virology 2008;82(24):12449-63.
2008: Nancy Gasper-Smith; Deanna M Crossman; John F Whitesides; Nadia Mensali; Janet S Ottinger; Steven G Plonk; M Anthony Moody; Guido Ferrari; Kent J Weinhold; Sara E Miller; Charles F Reich; Li Qin; Steven G Self; George M Shaw; Thomas N Denny; Laura E Jones; David S Pisetsky; Barton F Haynes
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.
Journal of virology 2008;82(15):7700-10.
2008: Geoffrey J Gorse; Lindsey R Baden; Margaret Wecker; Mark J Newman; Guido Ferrari; Kent J Weinhold; Brian D Livingston; Tonya L Villafana; Hongli Li; Elizabeth Noonan; Nina D Russell
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
Vaccine 2008;26(2):215-23.
2008: S Munir Alam; Richard M Scearce; Robert J Parks; Kelly Plonk; Steven G Plonk; Laura L Sutherland; Miroslaw K Gorny; Susan Zolla-Pazner; Stacie Vanleeuwen; M Anthony Moody; Shi-Mao Xia; David C Montefiori; Georgia D Tomaras; Kent J Weinhold; Salim Abdool Karim; Charles B Hicks; Hua-Xin Liao; James Robinson; George M Shaw; Barton F Haynes
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.
Journal of virology 2008;82(1):115-25.
2007: Nina D Russell; Barney S Graham; Michael C Keefer; M Juliana McElrath; Steven G Self; Kent J Weinhold; David C Montefiori; Guido Ferrari; Helen Horton; Georgia D Tomaras; Sanjay Gurunathan; Lynn Baglyos; Sharon E Frey; Mark MULLIGAN; Clayton D Harro; Susan P Buchbinder; Lindsey R Baden; William A Blattner; Beryl A Koblin; Lawrence Corey
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):203-12.
2006: Mark MULLIGAN; Nina D Russell; Connie Celum; J Kahn; E Noonan; David C Montefiori; Guido Ferrari; Kent J Weinhold; J M Smith; Rama Rao Amara; Harriet L Robinson
Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults.
AIDS research and human retroviruses 2006;22(7):678-83.
2005: Michael R Betts; Barbara Exley; David A Price; Anju Bansal; Zenaido Tres Camacho; Vanessa Teaberry; Sadie M West; David R Ambrozak; Georgia D Tomaras; Mario Roederer; J. Michael Kilby; Jim Tartaglia; Robert B Belshe; Feng Gao; Daniel C Douek; Kent J Weinhold; Richard A Koup; Paul A Goepfert; Guido Ferrari
Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(12):4512-7.
2005: Susan S Kaplan; Guido Ferrari; Terri Wrin; Nicholas S Hellmann; Georgia D Tomaras; Victoria E Gryszowka; Susan A Fiscus; Kent J Weinhold; Charles B Hicks
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
AIDS research and human retroviruses 2005;21(1):13-6.
2004: David C Montefiori; Barbara Metch; M Juliana McElrath; Steven G Self; Kent J Weinhold; Lawrence Corey
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.
The Journal of infectious diseases 2004;190(11):1962-9.
2004: Helen Horton; Nina Russell; Erin Moore; Ian Frank; Ruth Baydo; Colin Havenar-Daughton; Deborah Lee; Mark Deers; Michael G Hudgens; Kent J Weinhold; M Juliana McElrath
Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells.
The Journal of infectious diseases 2004;190(9):1692-6.
2004: Guido Ferrari; Wesley Neal; Janet Ottinger; Anizsa M Jones; Bradley H Edwards; Paul A Goepfert; Michael R Betts; Richard A Koup; Susan Buchbinder; M Juliana McElrath; Jim Tartaglia; Kent J Weinhold
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):2126-33.
2004: Guido Ferrari; Jeffrey R Currier; Matthew E Harris; Stella Finkelstein; Angelica de Oliveira; Debra Barkhan; Josephine H Cox; Michael Zeira; Kent J Weinhold; Nancy L Reinsmoen; Francine E McCutchan; Deborah L Birx; Saladin Osmanov; Shlomo Maayan
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians.
Human immunology 2004;65(6):648-59.
2004: William A Blattner; Kris Ann K Kwiterovic Oursler; Farley R Cleghorn; Man E Charurat; Anne M Sill; Courtenay Bartholomew; Noreen Jack; Thomas O'Brien; Jeffrey Edwards; Georgia D Tomaras; Kent J Weinhold; Michael Greenberg
Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
The Journal of infectious diseases 2004;189(10):1793-801.
2004: Peter F Wright; Jiri Mestecky; M Juliana McElrath; Michael C Keefer; Geoffrey J Gorse; Paul A Goepfert; Zina Moldoveanu; David Schwartz; Paul Spearman; Raphaelle El Habib; Michelle Donna Spring; Yuwei Zhu; Carol Smith; Jorge Flores; Kent J Weinhold
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
The Journal of infectious diseases 2004;189(7):1221-31.
2003: Susan A Sufka; Guido Ferrari; Victoria E Gryszowka; Terri Wrin; Susan A Fiscus; Georgia D Tomaras; Herman F Staats; Dhavalkumar D Patel; Gregory D Sempowski; Nicholas S Hellmann; Kent J Weinhold; Charles B Hicks
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
The Journal of infectious diseases 2003;187(7):1027-37.
2002: Kalpana Gupta; Michael G Hudgens; Lawrence Corey; M Juliana McElrath; Kent J Weinhold; David C Montefiori; Geoffrey J Gorse; Sharon E Frey; Michael C Keefer; Thomas G Evans; Raphael Dolin; David H Schwartz; Clayton D Harro; Barney Graham; Paul Spearman; Mark MULLIGAN; Paul A Goepfert
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.
Journal of acquired immune deficiency syndromes (1999) 2002;29(3):254-61.
2001: M Louise Markert; A P Alvarez-McLeod; Gregory D Sempowski; Laura P Hale; Joseph M Horvatinovich; Kent J Weinhold; John A Bartlett; T A D'Amico; Barton F Haynes
Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy.
AIDS research and human retroviruses 2001;17(17):1635-43.
2001: Guido Ferrari; W Neal; A Jones; N Olender; Janet Ottinger; Richard Ha; M Juliana McElrath; Paul A Goepfert; Kent J Weinhold
CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition.
Immunology letters 2001;79(1-2):37-45.
2001: A M Johnston; ME Valentine; Janet Ottinger; Ruth Baydo; Victoria E Gryszowka; CL Vavro; Kent J Weinhold; Marty St Clair; Ross E McKinney
Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
The Pediatric infectious disease journal 2001;20(10):941-6.
2001: J F Demarest; Noreen Jack; Farley R Cleghorn; ML Greenberg; Trevor L Hoffman; Janet Ottinger; Lori E Fantry; Jeffrey Edwards; T R O'Brien; K Cao; B Mahabir; William A Blattner; Courtenay Bartholomew; Kent J Weinhold
Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression.
AIDS research and human retroviruses 2001;17(14):1333-44.
2001: Richard A Kaslow; Charles A Rivers; Jianming "James" Tang; T J Bender; Paul A Goepfert; Raphaelle El Habib; Kent J Weinhold; Mark MULLIGAN
Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
Journal of virology 2001;75(18):8681-9.
2001: Melissa Fair Wellons; Janet Ottinger; Kent J Weinhold; Victoria E Gryszowka; Linda L Sanders; Lloyd J Edwards; Maria E Gooding; James R Thomasch; John A Bartlett
Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.
The Journal of infectious diseases 2001;183(10):1522-5.
2001: Robert B Belshe; C Stevens; Geoffrey J Gorse; Susan Buchbinder; Kent J Weinhold; Haynes W Sheppard; Donald Stablein; S Self; James McNamara; Sharon Frey; J Flores; Jean-Louis Excler; M Klein; R E Habib; AM Duliege; Clayton D Harro; Lawrence Corey; Michael C Keefer; Mark MULLIGAN; P Wright; Connie Celum; Franklyn N Judson; K Mayer; David J McKirnan; Michael Marmor; George E Woody
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
The Journal of infectious diseases 2001;183(9):1343-52.
2001: John S Lambert; Michael C Keefer; Mark MULLIGAN; David H Schwartz; Jiri Mestecky; Kent J Weinhold; C Smith; RH Hsieh; Zina Moldoveanu; Patricia Fast; B Forrest; W Koff
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.
Vaccine 2001;19(23-24):3033-42.
2001: Thomas G Evans; M Juliana McElrath; T Matthews; David Montefiori; Kent J Weinhold; Mark Wolff; Michael C Keefer; Esper Kallas; Lawrence Corey; Geoffrey J Gorse; Robert B Belshe; Barney S Graham; Paul Spearman; David H Schwartz; Mark MULLIGAN; Paul A Goepfert; Patricia Fast; Phillip W. Berman; M Powell; D Francis
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.
Vaccine 2001;19(15-16):2080-91.
2000: Guido Ferrari; DD Kostyu; J Cox; Deborah V Dawson; J Flores; Kent J Weinhold; Saladin Osmanov
Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
AIDS research and human retroviruses 2000;16(14):1433-43.
2000: Farley R Cleghorn; Noreen Jack; Jean K Carr; Jeffrey Edwards; B Mahabir; Anne M Sill; CB McDanal; S M Connolly; D Goodman; R Q Bennetts; T R O'Brien; Kent J Weinhold; Courtenay Bartholomew; William A Blattner; ML Greenberg
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(19):10532-7.
2000: Georgia D Tomaras; SF Lacey; CB McDanal; Guido Ferrari; Kent J Weinhold; ML Greenberg
CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(7):3503-8.
2000: M Louise Markert; Charles B Hicks; John A Bartlett; J L Harmon; Laura P Hale; ML Greenberg; Guido Ferrari; Janet Ottinger; A Boeck; A L Kloster; TM McLaughlin; KAREN BLEICH; R M Ungerleider; H Kim Lyerly; William E Wilkinson; Franck Rousseau; ME Heath-Chiozzi; JM Leonard; Ashley T Haase; George M Shaw; R Pat Bucy; D C Douek; Richard A Koup; Barton F Haynes; Dani P Bolognesi; Kent J Weinhold
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.
AIDS research and human retroviruses 2000;16(5):403-13.
2000: Renan C Castillo; Silvio Arango-Jaramillo; Rohan John; Kent J Weinhold; P Kanki; Lucy Minnich Carruth; David H Schwartz
Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity.
The Journal of infectious diseases 2000;181(3):897-903.
2000: Barton F Haynes; Hua-Xin Liao; Herman F Staats; M S Alam; Kent J Weinhold; David C Montefiori
HIV vaccine development at Duke University Medical Center.
Immunologic research 2000;22(2-3):263-9.
1999: Peter F Wright; John S Lambert; Geoffrey J Gorse; RH Hsieh; M Juliana McElrath; Kent J Weinhold; Diane Wara; Edwin L Anderson; Michael C Keefer; S Jackson; LJ Wagner; D P Francis; Patricia Fast; James McNamara
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.
The Journal of infectious diseases 1999;180(4):1080-8.
1999: Thomas G Evans; Michael C Keefer; Kent J Weinhold; Mark Wolff; David Montefiori; Geoffrey J Gorse; Barney S Graham; M Juliana McElrath; Mary Lou Clements-Mann; Mark MULLIGAN; Patricia Fast; MC Walker; Jean-Louis Excler; AM Duliege; Jim Tartaglia
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
The Journal of infectious diseases 1999;180(2):290-8.
1999: Barton F Haynes; Laura P Hale; Kent J Weinhold; Dhavalkumar D Patel; Hua-Xin Liao; PB Bressler; D M Jones; J F Demarest; K Gebhard-Mitchell; Ashley T Haase; John A Bartlett
Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.
The Journal of clinical investigation 1999;103(4):453-60.
1998: Robert B Belshe; Geoffrey J Gorse; Mark MULLIGAN; Thomas G Evans; Michael C Keefer; Jean-Louis Excler; AM Duliege; Jim Tartaglia; W I Cox; James McNamara; K L Hwang; A Bradney; David Montefiori; Kent J Weinhold
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.
AIDS (London, England) 1998;12(18):2407-15.
1998: John A Bartlett; C Berend; G R Petroni; Janet Ottinger; D L Tyler; C Pettinelli; Kent J Weinhold
Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042.
The Journal of infectious diseases 1998;178(4):1170-3.
1998: Douglas S Tyler; S D Stanley; John A Bartlett; Dani P Bolognesi; Kent J Weinhold
Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
The Journal of surgical research 1998;79(2):115-20.
1998: John A Bartlett; Steven Wasserman; Charles B Hicks; Robert Dodge; Kent J Weinhold; Carol O Tacket; N Ketter; A E Wittek; TJ Palker; Barton F Haynes
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.
AIDS (London, England) 1998;12(11):1291-300.
1998: Mary Lou Clements-Mann; Kent J Weinhold; TJ Matthews; Barney S Graham; Geoffrey J Gorse; Michael C Keefer; M Juliana McElrath; RH Hsieh; Jiri Mestecky; Susan Zolla-Pazner; J Mascola; David H Schwartz; Robert Siliciano; Lawrence Corey; Peter F Wright; Robert B Belshe; Raphael Dolin; S Jackson; S Xu; Patricia Fast; MC Walker; Donald Stablein; Jean-Louis Excler; Jim Tartaglia; E Paoletti
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1998;177(5):1230-46.
1998: Farley R Cleghorn; Noreen Jack; J R Murphy; Jeffrey Edwards; B Mahabir; R Paul; T O'Brien; M Greenberg; Kent J Weinhold; Courtenay Bartholomew; Ron Brookmeyer; William A Blattner
Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
American journal of epidemiology 1998;147(9):834-9.
1998: SF Lacey; Kent J Weinhold; Chin Ho Chen; CB McDanal; C Oei; ML Greenberg
Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual.
AIDS research and human retroviruses 1998;14(6):521-31.
1998: Lawrence Corey; M Juliana McElrath; Kent J Weinhold; T Matthews; Donald Stablein; B Graham; Michael C Keefer; David H Schwartz; Geoffrey J Gorse
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1998;177(2):301-9.
1997: Guido Ferrari; C Berend; Janet Ottinger; Richard K Dodge; J Bartlett; J Toso; D Moody; Jim Tartaglia; W I Cox; E Paoletti; Kent J Weinhold
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy.
Blood 1997;90(6):2406-16.
1997: Guido Ferrari; W Humphrey; M Juliana McElrath; Jean-Louis Excler; AM Duliege; M L Clements; Lawrence Corey; Dani P Bolognesi; Kent J Weinhold
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1396-401.
1997: M Juliana McElrath; Robert Siliciano; Kent J Weinhold
HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation.
AIDS research and human retroviruses 1997;13(3):211-6.
1997: ML Greenberg; SF Lacey; Chin Ho Chen; Dani P Bolognesi; Kent J Weinhold
Noncytolytic CD8 T cell-mediated suppression of HIV replication.
Springer seminars in immunopathology 1997;18(3):355-69.
1996: Barney S Graham; Michael C Keefer; M Juliana McElrath; Geoffrey J Gorse; David H Schwartz; Kent J Weinhold; TJ Matthews; J R Esterlitz; F Sinangil; Patricia Fast
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.
Annals of internal medicine 1996;125(4):270-9.
1996: Michael C Keefer; Barney S Graham; M Juliana McElrath; TJ Matthews; Donald Stablein; Lawrence Corey; Peter F Wright; D Lawrence; Patricia Fast; Kent J Weinhold; RH Hsieh; David Chernoff; C Dekker; Raphael Dolin
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 1996;12(8):683-93.
1996: Geoffrey J Gorse; Michael C Keefer; Robert B Belshe; TJ Matthews; B D Forrest; RH Hsieh; W C Koff; Carl Hanson; Raphael Dolin; Kent J Weinhold; Sharon E Frey; N Ketter; Patricia Fast
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
The Journal of infectious diseases 1996;173(2):330-9.
1996: J F Toso; C Oei; F Oshidari; J Tartaglia; E Paoletti; H Kim Lyerly; S Talib; Kent J Weinhold
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
Cancer research 1996;56(1):16-20.
1995: M Girard; B Meignier; Françoise Barré-Sinoussi; Marie Paule Kieny; T Matthews; E Muchmore; P L Nara; Q Wei; Laurence Rimsky; Kent J Weinhold
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.
Journal of virology 1995;69(10):6239-48.
1995: J F Toso; C H Chen; J R Mohr; L Piglia; C Oei; G Ferrari; ML Greenberg; Kent J Weinhold
Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.
The Journal of infectious diseases 1995;172(4):964-73.
1995: G Ferrari; K King; K Rathbun; C A Place; M V Packard; John A Bartlett; Dani P Bolognesi; Kent J Weinhold
IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Clinical and experimental immunology 1995;101(2):239-48.
1995: D DeNofrio; G Radcliff; Kent J Weinhold; S M Denning
CD3 delta and epsilon gene expression in CD3-CD16+ natural killer cell clones derived from thymic precursors.
Human immunology 1995;43(4):283-94.
1995: P M Ahearne; R A Morgan; Mark W Sebastian; Dani P Bolognesi; Kent J Weinhold
Multiple CTL specificities against autologous HIV-1-infected BLCLs.
Cellular immunology 1995;161(1):34-41.
1994: David H Schwartz; U Sharma; M Busch; Kent J Weinhold; T Matthews; J Lieberman; D Birx; H Farzedagen; Joseph B Margolick; Thomas C Quinn
Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.
AIDS research and human retroviruses 1994;10(12):1703-11.
1994: Robert B Belshe; Barney S Graham; Michael C Keefer; Geoffrey J Gorse; P Wright; Raphael Dolin; T Matthews; Kent J Weinhold; Dani P Bolognesi; R Sposto
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
JAMA : the journal of the American Medical Association 1994;272(6):475-80.
1994: G Ferrari; C A Place; P M Ahearne; S M Nigida; Larry O Arthur; Dani P Bolognesi; Kent J Weinhold
Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees.
Journal of acquired immune deficiency syndromes 1994;7(4):325-31.
1994: Haynes W Sheppard; S H Bridges; B J Mathieson; MC Walker; Kent J Weinhold
Conference on advances in AIDS vaccine development--1993. Summary: correlates of HIV Immunity Working Group.
AIDS research and human retroviruses 1994;10 Suppl 2():S171-6.
1993: C H Chen; Kent J Weinhold; John A Bartlett; Dani P Bolognesi; ML Greenberg
CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.
AIDS research and human retroviruses 1993;9(11):1079-86.
1993: G Ferrari; Janet Ottinger; C Place; S M Nigida; Larry O Arthur; Kent J Weinhold
The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees.
AIDS research and human retroviruses 1993;9(7):647-56.
1993: Emmanuel B Walter; Kent J Weinhold; Catherine M Wilfert
Enhanced p24 antigen detection in sera from human immunodeficiency virus-infected children.
The Pediatric infectious disease journal 1993;12(1):94-6.
1992: A J Langlois; Kent J Weinhold; TJ Matthews; ML Greenberg; Dani P Bolognesi
Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus.
AIDS research and human retroviruses 1992;8(9):1641-52.
1992: Kent J Weinhold; Jim Tartaglia; E Paoletti; B Graham; David H Schwartz; J McElrath; N Roberts; Geoffrey J Gorse
Specific activation strategies for amplification of low CTL signals.
AIDS research and human retroviruses 1992;8(8):1373.
1992: A J Langlois; Kent J Weinhold; TJ Matthews; ML Greenberg; Dani P Bolognesi
The ability of certain SIV vaccines to provoke reactions against normal cells.
Science (New York, N.Y.) 1992;255(5042):292-3.
1991: M K Hart; Kent J Weinhold; Richard M Scearce; E M Washburn; C A Clark; TJ Palker; Barton F Haynes
Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(21):9448-52.
1991: S M Denning; D M Jones; Russell E Ware; Kent J Weinhold; M B Brenner; Barton F Haynes
Analysis of clones derived from human CD7+CD4-CD8-CD3- thymocytes.
International immunology 1991;3(10):1015-24.
1991: K C Stine; Douglas S Tyler; S D Stanley; John A Bartlett; Dani P Bolognesi; Kent J Weinhold
The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
Cellular immunology 1991;136(1):165-72.
1991: A J Langlois; Kent J Weinhold; TJ Matthews; Dani P Bolognesi
In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251.
AIDS research and human retroviruses 1991;7(8):713-20.
1991: Kent J Weinhold
Anti-HIV-1 ADCC: clinical and therapeutic implications.
Biotechnology therapeutics 1991;2(1-2):147-57.
1990: Douglas S Tyler; S D Stanley; Susan Zolla-Pazner; M K Gorny; P P Shadduck; A J Langlois; TJ Matthews; Dani P Bolognesi; TJ Palker; Kent J Weinhold
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(10):3276-82.
1990: Emmanuel B Walter; Ross E McKinney; B A Lane; Kent J Weinhold; Catherine M Wilfert
Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis.
The Journal of pediatrics 1990;117(2 Pt 1):255-8.
1990: Douglas S Tyler; S D Stanley; C A Nastala; A A Austin; John A Bartlett; K C Stine; H Kim Lyerly; Dani P Bolognesi; Kent J Weinhold
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(9):3375-84.
1990: Kent J Weinhold; Douglas S Tyler; H Kim Lyerly
Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
Developments in biological standardization 1990;72():343-8.
1989: Douglas S Tyler; H Kim Lyerly; Kent J Weinhold
Anti-HIV-1 ADCC.
AIDS research and human retroviruses 1989;5(6):557-63.
1989: K C Stine; Dani P Bolognesi; Kent J Weinhold
Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.
Journal of biological response modifiers 1989;8(5):501-10.
1989: Kent J Weinhold; H Kim Lyerly; S D Stanley; A A Austin; TJ Matthews; Dani P Bolognesi
HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(9):3091-7.
1989: Douglas S Tyler; C L Nastala; S D Stanley; TJ Matthews; H Kim Lyerly; Dani P Bolognesi; Kent J Weinhold
GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(4):1177-82.
1988: R W Buckheit; Dani P Bolognesi; Kent J Weinhold
The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus.
Virology 1988;166(2):533-41.
1988: S Chaffee; J M Leeds; TJ Matthews; Kent J Weinhold; M Skinner; Dani P Bolognesi; Michael S Hershfield
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.
The Journal of experimental medicine 1988;168(2):605-21.
1988: P M Ahearne; TJ Matthews; H Kim Lyerly; G C White; Dani P Bolognesi; Kent J Weinhold
Cellular immune response to viral peptides in patients exposed to HIV.
AIDS research and human retroviruses 1988;4(4):259-67.
1988: M A Skinner; R Ting; A J Langlois; Kent J Weinhold; H Kim Lyerly; K Javaherian; TJ Matthews
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.
AIDS research and human retroviruses 1988;4(3):187-97.
1988: Kent J Weinhold; H Kim Lyerly; TJ Matthews; Douglas S Tyler; P M Ahearne; K C Stine; A J Langlois; D T Durack; Dani P Bolognesi
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
Lancet 1988;1(8591):902-5.
1988: TJ Palker; M E Clark; A J Langlois; TJ Matthews; Kent J Weinhold; Richard R Randall; Dani P Bolognesi; Barton F Haynes
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(6):1932-6.
1988: A J Langlois; TJ Matthews; Kent J Weinhold; S Chaffee; Michael S Hershfield; Dani P Bolognesi
Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay.
AIDS research and human retroviruses 1988;4(1):63-9.
1988: R W Buckheit; J Kurtzberg; Dani P Bolognesi; Kent J Weinhold
The coenrichment of stem cells, prothymocytes, and stromal elements with ecotropic retrovirus-producing cells from the bone marrow of leukemia-prone AKR mice.
Virology 1988;162(2):354-61.
1988: R W Buckheit; S N Liberman; Dani P Bolognesi; Kent J Weinhold
The effects of leukemosuppressive immunotherapy on thymic infectious cell centers in AKR mice.
Thymus 1988;12(3):143-56.
1988: K Thiel; E V Genovesi; J Dirk Iglehart; Dani P Bolognesi; Kent J Weinhold
Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity.
Advances in experimental medicine and biology 1988;239():169-83.
1987: H Kim Lyerly; D L Reed; TJ Matthews; A J Langlois; P A Ahearne; S R Petteway; Kent J Weinhold
Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
AIDS research and human retroviruses 1987;3(4):409-22.
1987: TJ Matthews; H Kim Lyerly; Kent J Weinhold; A J Langlois; J Rusche; S D Putney; Robert C Gallo; Dani P Bolognesi
Prospects for development of a vaccine against HTLV-III-related disorders.
AIDS research and human retroviruses 1987;3 Suppl 1():197-206.
1987: Joanne Kurtzberg; Henry S Friedman; Thomas R Kinney; S Chaffee; K Stine; J M Falletta; Kent J Weinhold
Management of human immunodeficiency virus-associated thrombocytopenia with intravenous gamma globulin.
The American journal of pediatric hematology/oncology 1987;9(4):299-301.
1986: S D Putney; T J Matthews; W G Robey; D L Lynn; M Robert-Guroff; W T Mueller; A J Langlois; J Ghrayeb; S R Petteway; Kent J Weinhold
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.
Science (New York, N.Y.) 1986;234(4782):1392-5.
1981: J Dirk Iglehart; Kent J Weinhold; G Huper; K Thiel; Dani P Bolognesi
In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Journal of the National Cancer Institute 1981;67(1):123-30.